Back to Awarded Treatment Trials
Awarded Trial: 17T-003
Grant ID
17T-003
Illness
Schizophrenia
Primary Drug/Intervention
Methotrexate
Primary Dosage
15 mg/week
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Mark Weiser
Sample Size
100
Duration of Study Period for Each Subject
112 days
Outcome Measurements
Primary outcome measure: PANSS positive score at the end of the trial. Secondary outcome measures: PANSS total, negative and general psychopathology scales, Clinical Global Impression Scale-Severity (CGI-S) and Global Impression Scale-Improvement (CGI-I), Social Functioning Scale Assessment (PSP) and rates of drop outs before the end of the trial.
Results
N/A
Publication
N/A
Link
N/A
PI Name
Mark Weiser
Degree
MD
Center
N/A
Institution
Sheba Medical Center
Address
Tel Hashomer
City or Town
Ramat Gan
State or Province
N/A
Zip or Postal Code
N/A
Country
Israel
Email Address
mweiser@netvision.net.il